TGOD.TO The Green Organic Dutchman (TSX) intraday C$0.17 18 Mar 2026: monitor volume-driven pivot

TGOD.TO stock is the Toronto Stock Exchange’s most active cannabis name intraday on 18 Mar 2026, trading 19,704,275.00 shares. The Green Organic Dutchman Holdings Ltd. (TGOD.TO) sits at C$0.17 after opening at C$0.26 and hitting a day high of C$0.22. Volume is more than twelve times average, a sign of strong short-term trading interest. We examine why the heavy flows matter for price, liquidity, and near-term risk using fundamentals, technicals, and our AI-powered market analysis platform.

TGOD.TO stock intraday price action

TGOD.TO stock is trading at C$0.17 on the TSX during intraday session on 18 Mar 2026. Volume today is 19,704,275.00, versus an average volume of 1,585,835.00, producing a relative volume of 12.43.

TGOD.TO stock fundamentals and valuation

The Green Organic Dutchman Holdings Ltd. shows trailing EPS of -0.23 and a trailing P/E of -0.74, reflecting losses. Book value per share is 0.38, and price-to-book is 0.45, implying the market values assets below book. Current ratio is 0.67, debt-to-equity is 0.33, and enterprise value is 35,113,000.00 CAD, which highlights tight liquidity and modest leverage for a small-cap cannabis name.

TGOD.TO stock technicals and volume signals

Short-term technicals show a 50-day average price of 0.24 and a 200-day average of 0.31. The day range is C$0.17 to C$0.22, testing intraday resistance near the 50-day average. High volume and a relative volume of 12.43 point to active trading and potential volatility near support at C$0.17.

Meyka AI rates TGOD.TO stock grade

Meyka AI rates TGOD.TO with a score out of 100. The platform reports a score of 62.98 out of 100, grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are informational only and not financial advice.

TGOD.TO stock sector context, risks and opportunities

TGOD.TO operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic, where peers show weaker profitability metrics. Cannabis firms face inventory and cash conversion cycle challenges; TGOD.TO shows days-of-inventory 453.70 and days-sales-outstanding 172.91, indicating working capital pressure. Opportunities include premium organic product positioning and European CBD distribution, but liquidity risk and negative margins remain clear near-term risks.

TGOD.TO stock price forecast and analyst targets

Meyka AI’s forecast model projects a monthly price of C$0.17, matching the current price and implying 0.00% near-term upside from the model. Forecasts are model-based projections and not guarantees. For planning, we frame two reference targets: a near-term resistance target of C$0.30 and a longer-range scenario to previous highs at C$0.65, with downside risk to C$0.10 if liquidity dries up.

Final Thoughts

TGOD.TO stock is the intraday market leader by volume on 18 Mar 2026, trading C$0.17 on the TSX with 19,704,275.00 shares changing hands. Heavy volume raises short-term trading opportunities and risk. Fundamentals show negative EPS of -0.23, a price-to-book of 0.45, and a strained current ratio of 0.67, underlining liquidity pressure. Meyka AI’s forecast model projects C$0.17 monthly, implying 0.00% model upside versus current price; forecasts are not guarantees. We view the stock as a speculative trade for active traders, with a measured hold stance for longer-term investors until margins and working capital improve. Monitor volume, the 50-day average (0.24), and the near-term support at C$0.17 before adding exposure. For more real-time context, consult the company site and chart updates via our AI-powered market analysis tools.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.